May 14

Do patients of CAM-trained GPs have 15 percent less healthcare costs? Nope, myth busted!

Apart from weird theories which are put forward to explain how homeopathy, acupuncture and similar types of quackery work, proponents of these alternative treatments are spreading two other myths: in a breakthrough report the Swiss government has affirmed homeopathy as effective treatment and Dutch research by Prof. Peter Kooreman and Erik Baars shows that General Practioners (GPs) who are trained in Complementary and Alternative Medicine (CAM) work cheaper: their patients have on average 15 percent lower healthcare costs than those of regular GPs.
Both myths can be found for instance together in a Huffington Post blog by ‘Mr Homeopathy’ Dana Ullman. Views on the status of the ‘Swiss report’, which accord more to reality, can be found here and here. In this blog I will tackle the other myth, that CAM GPs have been shown to work 15 percent cheaper in the Netherlands. 

dr. Erik Baars

Erik Baars

First critics: The Dutch Society against Quackery
The research of Kooreman and Baars (K&B) was mainly brought to public attention via a newspaper article (De Volkskrant , June 8th 2010) and rather quickly criticized by dr. Cees Renckens en Jan Willem Nienhuys of the Society against Quackery. A big problem for a direct comparison of the patients of regular and CAM GPs is that these populations differ quite a bit in socioeconomic status and that factor is directly related to health (and costs for healthcare). Strangely enough, higher educated people, who tend to have better socioeconomic circumstances, seem to be more attracted to CAM. So if it might seem that patients of CAM GPs are healthier, it probably has more to do with their better starting position and not by CAM treatments. Of course K&B were aware of this problem and they controlled for this by comparing the data (which they got from big health insurer) on the lowest level of the Dutch zipcode system (about 16 households). On this level socioeconomic differences are expected to be not that big and it looks like a reasonable approach.
The newspaper article mentioned that the study showed 15 percent lower costs for patients of CAM GPs, but Renckens and Nienhuys noticed that this figure could not be found in the article itself. Only a difference of  7 percent was given and this was a not significant difference on the data before correction on socioeconomic factors. They did see that a subgroup, people older than 75 visiting an anthroposophic GP, were 400 euros cheaper (per quarter) which amounts to a difference of about 30 percent in comparison to a regular GP. This huge difference was only just significant, so either the number of patients in this group was quite low or variance in costs was huge (or both). According to the Society against Quackery Kooreman let them know that the analysis of Renckens and Nienhuys clearly showed that the Society lacked the expertise to judge his research.

Discussion in The European Journal of Health Economics
Renckens and Nienhuys had ended their comments remarking that it might be wiser to wait until the article would have been accepted by a serious scientific journal before diving deep in the statistics used. Until then it was only made available via Kooreman’s website as ‘submitted article’. The article was accepted in 2011 and published in December 2012 in The European Journal of Health Economics (EJHE) as Patients whose GP knows complementary medicine tend to have lower costs and live longer (Open Access). Via a Rbutr-link I became aware of this and the recent comments on the article by Christopher Sampson et al.(or pdf from Sampson’s site). The most important problems they have with it, make come down to:

  • The lack of attention K&B give to the problem of multiple testing. If you compare the regular and CAM-groups on many subcategories (by age, kind of medical intervention) you have to be very careful not to identify accidental outliers as significant  differences;
  • In the article K&B consider only one outcome measure which directly tells something about the health of the patients: mortality. This is a very important observation, I think. A major weakness of this study is that it doesn’t relate any type of medical intervention (regular or CAM) to the costs. You could have done the same analysis classifying the GPs by their favorite car brand. The outcome might then have been that Mercedes-driving GPs work cheaper, but I doubt that anyone would have taken it seriously;
  • On the result in the abstract as stated by K&B (‘Patients whose GP has additional CAM training have 0–30% lower healthcare costs and mortality rates.’) they write: ’This is a misleading and,arguably, disingenuous claim.’;
  • Sampson et al. also worry that this result will be used for CAM propaganda: ‘We believe these findings could be widely cited, as is commonplace for ‘supportive’ CAM research.‘ That would be a bad thing because ’The study does not demonstrate that GP-CAM training is associated with either reduced healthcare costs or reduced mortality. Academics have a responsibility to communicate their research carefully and without misinterpretation. Kooreman and Baars have failed to do this.’

K&B replied in the same issue. With regard to multiple testing, they note that they found so many significant results (around 17–21 % of the costs coefficients) that it is very unlikely that these are all false positives. From a statistical viewpoint, quite a peculiar way of dealing with this issue. About that 0-30% interval they tell us that the 30% follows from the 400 euros, which I mentioned before (anthroposophic GP, 75+), as well as the lower mortality they found (significant at 10% level,  for men only). And we should also note that ’0′ is included in both intervals, they tell us. How we should look at these rough ranges is still puzzling me. It seems to me a very unclear way of reporting a ‘result’, but maybe they just want to make clear that they do not claim to have found rock solid evidence. The last bit of their reply is:

Throughout, we have been careful to stress the limitations of our study and the need for further research based on better datasets (and we continue to do so in our contacts related to this study with the media, practitioners, and other parties). The commentators have not provided any insights beyond those already available in our original paper. We hope that their future contributions (and the associated journal space) will take the form of substantive research on this important topic.

In my opinion Sampson et al. put forward some very strong arguments and the answers by K&B are not satisfactory. Do they really think they can bluff their way out doing so?

But where is the ’15 percent’ coming from?
I became quite curious to find the origin of the claim that CAM GPs work 15 percent cheaper. First I contacted Sampson. He hadn’t not yet seen the K&B reply and was quite surprised to hear that the study was already cited all over the Internet by CAM supporters, exactly like they had warned for. Sampson will probably come with another reply to K&B to explain why their answers are not satisfactory.

I was getting the idea that the ’15 percent’ might have been wrongfully derived from the result as stated in the abstract.

Patients whose GP has additional CAM training have 0–30% lower healthcare costs and mortality rates, depending on age groups and type of CAM. The lower costs result from fewer hospital stays and fewer prescription drugs

Maybe some people thought of this rough 0-30% range as a proper confidence interval? Then it would make sense to assume the actual result to be exactly in the middle. From the answers K&B gave, it is already clear that is not a confidence interval, but is it a fair summary of what they did found? The figures regarding the costs come from table 3:

Table 3 from the Kooreman & Baars article.  First three columns give corrected differences in costs per category (per quarter in euros). Yellow  highlighting by me.

Table 3 from the Kooreman & Baars article. First three columns give corrected differences in costs per category (per quarter, in euros). Yellow highlighting by me.

We find the (approximately) 400 euro reduced costs for patients of 75 years and older at anthroposophic GPS, but we also find a group which is worse off: younger than 25 at homeopathic GPs. That difference amounts to 100 euros more health costs per quarter, which is 47 percent higher than the costs for patients of regular GPs. So wouldn’t it be more fair to give the result of this research as an interval running from -47% to 30%? To get a clearer view on what this figures mean, it would have been nice to know the number of patients in each category, standard deviations and p-values. Therefore I wrote Kooreman an e-mail asking about these things.

Before he answered I had already found out that it had not been misinterpretated by De Volkskrant; the ’15 percent’ was in the press release of Tilburg University. And Baars mentioned it in a radio interview (Hoe?Zo! radio June 9th 2010, starting from 19.05, in Dutch). Kooreman did not show a great appetite in discussing the issues via mail and mainly pointed out that the press release had stated ‘approximately 15 percent’ not just ’15 percent’. It’s a pity he never sent me the underlying figures of table 3 as I had requested (repeatedly). I let him know that I couldn’t find a responsible way of translating a non significant difference of 7% into ’approximately 15 percent’; but alas, no response after that.
In the end I did found out where this ’15 percent’ originates from. K&B wrote an abstract for a congress on Integrative Medicine in December 2010, where they would be presenting their study. Deadline for abstracts was May 31st 2010. The press release, following a couple of days later, is probably based on the conclusions therein (emphasis by me):

Conclusions: There is evidence that treatment by GPs who completed additional training in complementary medicine (anthroposophic medicine, homeopathy or acupuncture) results in approximately 15% health care cost reduction.

 

prof. dr. Peter Kooreman

prof. Peter Kooreman

Misleading?
I found more references made by Kooreman to this study: an opinion article in another newspaper and a book chapter, all in Dutch so I’ll just briefly deal with those here. The ’15 percent’ is not mentioned, but he is playing around with the result in an other way. In the newspaper article he writes: “Recent research shows that GPs who have been trained in acupuncture, antroposophic medicine or homoeopathy after their regular studies, work cheaper than regular GPs, even if you correct in the best way for differences in patients backgrounds. Furthermore their patients live longer.” While in the book it is stated as “Based on data from a Dutch health insurer Kooremans and Baars find clues that … etc.” (emphasis by me).
On several websites the K&B article is referenced by a slightly different title: ‘Patients Whose GP Knows Complementary Medicine Have Lower Costs and Live Longer’ in stead of ‘Patients whose GP knows complementary medicine tend to have lower costs and live longer’. I first thought these websites might present it deliberately misleading (mainly because Ullman does so as well), but then I noticed that it was actually the original title. It was changed into the weaker version when published in EJHE.
Kooreman replaced the original submitted version on his website with the one published in EJHE. In doing so all the weblinks point to the most recent version, although in many cases now using the wrong title. Even Kooreman forgot to change the title in his curriculum vitae (up to today at least). The different versions can also be found via the Tilburg University Repository (from which we can see it had already been published before in a German journal on acupuncture).

Conclusions
To me it looks like Kooreman and Baars spiced up the actual result of their research from a realistic ‘we didn’t find a significant difference’ to something that suited them better. It might be a bit annoying that people like Renckens, Nienhuys and myself question the result, but those skeptic sounds can be set away as the biased criticism you can expect from self proclaimed fighters of quackery. It surprises me though, that they try to deal with criticism from scientific peers in similar fashion.
In contrast to this behavior Kooreman wrote to me that he had always insisted on careful interpretation of their findings. In a speech at a recent congress in The Netherlands (on Integrative Medicine) he mentioned that many CAM supporting websites had brought the result as if it proved that CAM treatment is cost effective, while it only can say something about the cost efficiency of CAM GPs, without being clear whether this is actually caused by using CAM treatments instead of regular care. On top of that, he pointed to the reports about the Excellence in Integrative Medicine Research Award Baars and he received at the European Congress for Integrative Medicine for their study. Those reports omit to mention that this prize was sponsored by Heel, a big homeopathic pharma company in Germany. And according to Kooreman, it would have been better to mention this before other parties find out.
This sounds very reasonable and correct, but nowhere does he acknowledge that the main result of the study itself is being communicated in misleading ways, also by the authors themselves. The ’15 percent’ even popped up again in the press release announcing that specific congress.

 

Translated and slightly adapted from a blog I wrote on Kloptdatwel.nl (in Dutch): Alternatieve huisartsen werken 15 procent goedkoper? Een verzinsel!

Apr 28

Egyptian hepatitis C detector changes shape. Where’s the dowsing rod?

A couple of weeks ago there was a little row over an article in The Guardian. Their correspondent in Egypt had written a piece about a new detector used by Egyptian doctors to detect people with hepatitis C, with astonishing good results. Problematic was the absence of a plausible explanation how the device could work as described. Moreover this device had a striking resemblance to the bogus bomb detectors which were sold to countries like Iraq and may have been responsible for the dead of hundreds of people, because the devices failed to detect car bombs at checkpoints. Last week James McCormick, who made millions selling thousands of these devices to Iraq and other countries, was found guilty of fraud.
These dowsing rod like devices have been sold for detecting all kind of materials, ranging from golf balls to ivory. Detecting a virus inside a human body with it, as Dr Gamal Shiha is claiming to do, is something new.
The detectors don’t work and generally don’t contain a bit of the advanced electronics which supposedly operates them. It’s all a big scam and that has been known for quite some time. The devices sometimes seem to work if you know that the object of investigation contains the material you want to detect. That’s because of the ideomotor effect, as Chris French wrote a couple of days ago.

Regarding the hepatitis C detector, The Guardian set the record straight by publishing good articles by Suzi Gage and Síle Lane on this matter. In the comments on those articles one of the involved(?) Egyptian researchers wrote that they would present the results of their research on the coming International Liver Congres in Amsterdam (EASL 2013). And indeed they were present with a poster presentation.
For the Dutch website Kloptdatwel I wrote about this and asked around if someone would be going to this congres and could give a good look at the presentation. The abstract could be found freely accessible; the e-Poster itself can only be viewed by registered visitors to the congres. Luckily, someone was so kind to send me pictures of it. Apart from the remarkable results they show something very peculiar:

eposter of Shiha e.a. on EASL 2013 congres in Amsterdam

e-Poster of Shiha e.a. on EASL 2013 congres in Amsterdam

A close-up of the apparatus is confusing me:

The new C-FAST prototype?

The new C-FAST prototype?

This device doesn’t look at all like the dowsing rod Shiha was using according to the articles in The Guardian. And there was even a picture of him handling it! In the first article it was mentioned however that there were also digital versions of the device. Are those the ones shown on the e-Poster? But which one did they use getting the reported results? And why didn’t they show the antenna version as well? Questions, questions …

 

Dr Gamal Shiha demonstrates the prototype of a device that he claims can remotely detect the hepatitis C virus. Photograph: Patrick Kingsley/Guardian

From The Guardian: “Dr Gamal Shiha demonstrates the prototype of a device that he claims can remotely detect the hepatitis C virus.” Photograph: Patrick Kingsley/Guardian

Image of the(?) C-FAST detector from the patent application

Image of the C-FAST detector from the patent application

 

Feb 18

Ants Performing Statistical Miracle under GSM Phone Radiation?

A startup company in The Netherlands got the opportunity  to promote their product in a news programme of the national public broadcaster: a nano foil which should protect mobile phone users from harmful radiation. The company also performed tests on ants, which show that this radiation is actually dangerous. These tests are a follow up on research done by a Belgian researcher, whose data seems ‘too good to be true’.

Remarkable news item retracted

A mobile phone with the miracle nano foil

A mobile phone with the miracle nano foil, claimed to be able to transform ‘chaotic’ into harmonic radiation.

On January 3rd 2013 the viewers of news programme NOS op 3 were shown an item about a new tech company in the south of The Netherlands. This company, Brainport Biotech Solutions, is developing a nano foil which applied to a mobile phone, should protect its user from harmful radiation. On the website of the company this is backed up by a lot of pseudo scientific crap: the material is able to change “chaotic radiation into a pattern of coherent (harmonic) waves of selected frequencies”.

The main reason I could think of why this business man was taken seriously by journalists is that he presented some scientific research which had shown desastrous effects of GSM radiation on ants. This research was done by Marie-Claire Cammaerts, a senior researcher at the Université libre de Bruxelles. I had already read something about it back in July 2012, but this was a good reason to have a closer look. What I found in the article doesn’t look good, and that’s not because of the poor ants’ health.

Read the rest of this entry »

Dec 22

So, why did we survive December 21st 2012?

After all those years in which we were fed stories on the ending of the Maya calendar and the terrible fate of our world, which was supposed to come with it, yesterday went by unexpectedly smoothly. What happened? Why went things wrong, I mean right! This morning I strolled along the shores of the World Wide Web looking for answers to inform our readers on Kloptdatwel and stumbled upon some blogs, which might shed a light on the events which did, or did not happen.

First some news from the Mayas themselves:

And there might have been a covert operation by a major tech company:

Finally I found a rather strange story concerning End-of-the-World thinking, a story with a Dutch connection:

 

 

 

Sep 07

The Stapel Fraud Anniversary and the Psychology of Meat

Press releases
Exactly a year ago Tilburg University announced in a press release that professor Diederik Stapel had been suspended after strong suspicions of scientific fraud had been brought forward. I was really surprised when I read about this later that day. Wasn’t he the same guy who had collaborated in the research which I had been analyzing a couple of days before? That research by Stapel, professor Marcel Zeelenberg (Tilburg University ) and professor Roos Vonk (Radboud University Nijmegen) had shown that people who were exposed to images of meat act more selfish and show more anti-social behaviour.

Does eating meat bring out the worst in a person?

About two weeks before (Aug 25th) another press release from my own university (not available online anymore, but here is a copy) had brought this peculiar result, which immediately attracted a lot of attention on blogs,Twitter and almost all newspapers. Vonk has a record of being an activist for animal rights and has been very critical of the meat consumption in our society, also because of the environmental problems that comes with it. So many critics of Vonk’s views on eating meat immediately saw this study (and how it was presented in the press release) as an abuse of science for her personal agenda.

There are still a lot of people who think that the Stapel fraud is directly connected with this study on the psychology of (eating) meat and that it actually led to the discovery of his massive fraud. But that’s not the case. Stapel probably faked the data for this one as well, but it was just coincidental that the two issues came up in the same period.

More on the meat study and the flaws in methodology of Stapel-like research

Aug 27

Warning to Traumeel Users Visiting the Netherlands

Traumeel is sold as a homeopathic product for the relief of muscular pain, bruising and specially promoted for sport injuries. Following a discussion on kloptdatwel.nl I decided to take a closer look at this, because it seems that in the Netherlands Traumeel is different than in the rest of the world. Probably that’s why it is sold under a (marginally) different name: Traumeel H instead of Traumeel S (could be ‘H’ for Holland and ‘S’ for Standard, I guess). But what could be the reason that customers in the Netherlands are offered a different product?

Arnica Montana, one of the main ingredients in Traumeel (image Wikimedia Commons)

When I first looked at the composition I thought ‘this is no real homeopathy‘ because the potencies are quite low. So low that you can actually still find molecules of the original stuff in it. The controversy around homeopathy usually focuses on the ultra diluted products in which you can find no trace of the mother tincture they started with.
But then I was told that  (EU regulations, probably) you can call any product homeopathic if it is derived via potentization from a mother tincture prepared according to homeopathic rules. The law doesn’t demand it has to be diluted until at least D12, or something like that. And it can even be a mixture of such diluted products.

So Traumeel actually contains a tiny bit of the ingredients listed, but that doesn’t mean that it works, of course. Convincing evidence for that doesn’t exist according to a Science Based Pharmacy blog post:

Clinical Trials

Heel makes a number of claims (pdf) about Traumeel, but none are backed up by persuasive evidence. Mostly they compare Traumeel to anti-inflammatory drugs like ASA and ibuprofen, claiming that Traumeel is faster, more effective, and has no side effects.

Unfortunately, there are no well-designed, double-blind, peer reviewed, head-to-head trials that have established this. This is unfortunate, because there’s no information to support the included dosages, nor to suggest that any of these ingredients would even be absorbed into the skin. However, the relatively vague claims that Traumeel is “well-tolerated” and has “almost no side effects” are very plausible, given there isn’t enough of any ingredient to have any medicinal effects.

[NB the original link to the claims (pdf) doesn't work, I think it's the document which can be found here].

A 2011 article in the International Journal of General Medicine is more positive on Traumeel, but that one is sponsored by the manufacturer thus should be read with some care. But as even that article doesn’t mention any research which compares Traumeel tablets alone with conventional treatment,  we can safely assume that there is no good evidence that the tablets actually work.
An even more detailed review of Traumeel and other homeopathic or herbal arnica creams can be found on saveyourself.ca: ‘Does Traumeel work?‘ Conclusion from that site:

A few tests of Traumeel and similar products have been mildly encouraging, but mostly old and poor quality one. In all good quality, modern scientific trials so far, they have faired no better than placebo. It is possible that a benefit can still be proven, but it is not likely.

read on for the differences in Traumeel S and Traumeel H

Aug 15

The Photography Tricks of Robbert van den Broeke

Dutch medium Robbert van den Broeke rose to fame in the Netherlands in the early 2000′s with his discovery of crop circles and contacts with deceased people. He made his appearance in several programmes on national TV. In 2005 he was exposed as a fraud by Rob Nanninga, board member of the Dutch Skeptical foundation Skepsis, when he used a non-existing word to describe the job of a deceased person from around 1800. This word, ‘genverbrander’, was found on a genealogical website as a typo for ‘geneverbrander’ (= someone who makes brandy), something Van den Broeke obviously had missed. He also made some photos in which images of deceased people appear. And he even managed to achieve this with people around him and using a camera which was not one of his own.

The devil which was photographed by Nanninga in ‘Van den Broeke’ style

Come back in 2012
After being exposed Van den Broeke was away from mainstream media for some years, but beginning 2012 he made a comeback with new photographs and videos on a brand new website. In april Nanninga also gave a very plausible explanation for his photography tricks. In an article on the Skepsis blog he explains how Van den Broeke most likely makes his ghost photos.
In short: you prepare an image on your computer in an image editing program, cut it out so that the background is empty and then print the image on transparent foil (the type we used to use in the age of overhead projectors). You then cut that transparent foil to easy concealable size and hold in in front of the camera lens when making your pictures. Doing so, Nanninga made some pretty convincing ‘Van den Broeke’-like photographs.

Read on: Van den Broeke tries to prove the skeptics wrong

Video

Great talk by Jamy Ian Swiss on skepticism at TAM 2012

YouTube Preview Image

A very inspiring talk by Jamy Ian Smith at TAM 2012. I share his vision on what skepticism should be about. Worth watching all 40 minutes!

Aug 06

About the study on effects of the workplace smoking ban in the Netherlands and what is wrong with it

About one and a half month ago I became involved in the discussion which started after publication of a study claiming that the implementation of a workplace smoking ban in the Netherlands has saved thousands of lives in the following years: Effect of smoke-free legislation on the incidence of sudden circulatory arrest in the Netherlands, De Korte-De Boer,  Heart e.al., (July 2012). Head of the research team, Prof. Onno van Schayck, could even be seen in the main news programme telling that more than 16.000 sudden circulatory arrests (SCA) probably had been prevented in four and a half years after the ban, based on an extrapolation of their findings to the whole Dutch population. This figure of 16.000 prevented SCA cases also featured prominently in the press release of Maastricht University and was picked up by many newspapers.

Not everybody was convinced, though. Science journalist Maarten Keulemans, working for one of the main newspapers, contacted me and asked if I would like to have a look at the statistics used in this study. He himself had already written a critical blog which started some sort of a row with the authors.
Keulemans points out that in the study period there was no decrease in SCA incidence at all! The authors only show that the trend in SCA incidence seems to ‘turn’ around at the time of implementation of the workplace smoking ban. The later implementation of a smoking ban in cafes and restaurants didn’t not show a positive effect in their data. On the contrary: SCA incidence even rose slightely.

Other relevant questions are brought forward by Keulemans as well: ‘is the population of this small part of the country (South Limburg) representative for the Netherlands as a whole?’, ‘how about the number op pensioners and unemployed in the sample population?’, etc., etc. But then he points to the main problem I think. It seems that the whole result can be the cause of the unexplained increase of SCA incidence in the period before the smoking ban! Hadn’t Van Schayck and his team just struck upon a statistical oddity and given it the wrong (but welcome) interpretation?

And now? What is wrong with the study? Read on to find out!

Jul 25

Memories of Shrink Chess

The b-file has just been emptied by White’s last move (Rb2-c2+), it has to disappear.

Last week I received an email asking some questions about a chess variant, Shrink Chess. My name was mentioned on the website www.chessvariants.org. Indeed, back in 1996 I had mailed the website owner, Hans Bodlaender, the rules of ‘Krimpschaak‘ (which is Dutch for Shrinking Chess). This brought back nice memories of playing this fun chess variation when I was at University studying Mathematics. And therefore I decided to write a somewhat more elaborate article on this website.

Shrink Chess

Older posts «